Metraipolis › archive › dc_06d486cfb3eb

Identifying risk factors associated with refractoriness to radioiodine therapy in differentiated thyroid cancer — Europe PMC PMID:40834361

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/40834361
DOI: 10.20945/2359-4292-2025-0032
License (as archived): solo-consultazione
Archived: 2026-11-10T12:02:58.579Z
SHA-256 of the archived text: cc9d154bcdbe20c12c71643cdb1bbf7a67a16d7ef265094c307676a263400592
Stable URL of this page: https://metraipolis.com/documento/dc_06d486cfb3eb

How to cite

Identifying risk factors associated with refractoriness to radioiodine therapy in differentiated thyroid cancer — Europe PMC PMID:40834361 — Europe PMC (en), https://europepmc.org/article/MED/40834361 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_06d486cfb3eb (Metraipolis archive dc_06d486cfb3eb, sha256 cc9d154bcdbe20c12c71643cdb1bbf7a67a16d7ef265094c307676a263400592)

BibTeX

@misc{dc06d486cfb3eb,
  title = {Identifying risk factors associated with refractoriness to radioiodine therapy in differentiated thyroid cancer — Europe PMC PMID:40834361},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40834361},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_06d486cfb3eb; sha256 cc9d154bcdbe20c12c71643cdb1bbf7a67a16d7ef265094c307676a263400592},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40834361. Agents can read the archived copy with the MCP tool read_document.